Literature DB >> 2856511

Enhanced oxidative response of polymorphonuclear leukocytes from synovial fluids of patients with rheumatoid arthritis.

B Dularay1, C J Elson, P A Dieppe.   

Abstract

Polymorphonuclear leukocytes (PMN) isolated from the synovial fluid (SF) of patients with rheumatoid arthritis (RA) exhibited an enhanced oxidative response to heat aggregated IgG (Hagg) and N-formyl-methionyl-leucyl-phenylalanine (FMLP) as compared with either autologous or normal blood PMN. Normal blood PMN pretreated with synovial fluid showed a significantly increased response to FMLP which was unaffected by prior dialysis of SF. The degree of enhancement produced varied between SF's and was dependent on the period for which cells were incubated and on the concentration of SF used. In contrast there was no enhancement of the oxidative response when Hagg was used as a stimulus. Indeed, SF produced a dose dependent inhibition of Hagg stimulated superoxide production. These observations suggest that SF's from patients with RA contain factors which both enhance and inhibit the oxidative response of PMN depending on the subsequent stimulus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2856511     DOI: 10.3109/08916938808997161

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  17 in total

1.  Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression.

Authors:  J A Quayle; F Watson; R C Bucknall; S W Edwards
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Inhibition of myeloperoxidase by synovial fluid and serum.

Authors:  B Dularay; C M Yea; C J Elson
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

3.  Activation of the neutrophil myeloperoxidase-H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

4.  Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis.

Authors:  A Bensouyad; A P Hollander; B Dularay; A E Bedwell; R A Cooper; C W Hutton; P A Dieppe; C J Elson
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

5.  Oxidative response of polymorphonuclear leucocytes to synovial fluids from patients with rheumatoid arthritis.

Authors:  B Dularay; J S Badesha; P A Dieppe; C J Elson
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

6.  Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

7.  Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis.

Authors:  F Watson; J J Robinson; M Phelan; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

8.  Activation of neutrophils by soluble and insoluble immunoglobulin aggregates from synovial fluid of patients with rheumatoid arthritis.

Authors:  J J Robinson; F Watson; M Phelan; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

9.  Activation of neutrophil reactive-oxidant production by synovial fluid from patients with inflammatory joint disease. Soluble and insoluble immunoglobulin aggregates activate different pathways in primed and unprimed cells.

Authors:  J Robinson; F Watson; R C Bucknall; S W Edwards
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

10.  Role of Fc gamma receptors in the activation of neutrophils by soluble and insoluble immunoglobulin aggregates isolated from the synovial fluid of patients with rheumatoid arthritis.

Authors:  J J Robinson; F Watson; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.